MoneyWorks4Me

Dr Reddys Laboratories informs about company updates

09 Mar 2017 Evaluate

Dr Reddys Laboratories has informed that the audit of Company’s formulation manufacturing facilty at Duwada, Visakhapatnam, by the US FDA, has been completed on March 08, 2017. The Company have been issued a Form 483 with 13 observations, which the Company is addressing.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..